Glipizide Tablet, Extended Release
Product Images NDC 59651-780

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Glipizide (NDC 59651-780). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (2.5 mg (30 Tablet Container))

Label for Glipizide Extended-Release Tablets 2.5 mg, film-coated, containing 30 tablets. Distributed by Aurobindo Pharma USA, Inc. Made in India. Includes storage instructions and a barcode. The label indicates the product is Rx only and advises protecting from moisture and humidity.*

FDA Label Image

Package Label-principal Display Panel (5 mg (30 Tablet Container))

Label for Glipizide Extended-Release Tablets, 5 mg, manufactured by Aurobindo Pharma Limited. The label states a count of 30 tablets, indicates it is for prescription use only, and includes storage instructions. Distributed by Aurobindo Pharma USA, Inc., with a barcode and note about printing coding information during packing.*

FDA Label Image

Package Label-principal Display Panel (10 mg (30 Tablet Container))

Label for Glipizide Extended-Release Tablets 10 mg film-coated tablets, containing Glipizide USP 10 mg. The package contains 30 tablets. Distributed by Aurobindo Pharma USA, Inc., and made in India by Aurobindo Pharma Limited. Storage instructions specify 20° to 25°C, protected from moisture and humidity. The label includes NDC 59651-782-30 and space for printing GTIN, serial number, expiry date, and lot number during packing.*

FDA Label Image

Chemical Structure (Glipizide Str)

Chemical structure of Glipizide, a sulfonylurea class compound. The diagram depicts atomic connectivity including a pyridine ring, sulfonylurea group, and cyclohexyl moiety, consistent with the structure of Glipizide used in extended-release tablets by Aurobindo Pharma Limited.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.